improv
sensit
specif
rapid
onestep
revers
transcript
loopmedi
isotherm
amplif
lamp
assay
target
untransl
region
utr
develop
detect
hepat
c
viru
hcv
infect
base
acceler
primer
ap
present
assay
name
aplamp
advantag
rapid
sensit
routin
lamp
method
possibl
apbas
amplif
pathway
reaction
reveal
restrict
enzym
digest
eletrophoresi
detect
limit
aplamp
assay
approxim
iuml
crossdetect
observ
assay
evalu
clinic
specimen
result
indic
suitabl
simplic
test
rapid
diagnost
tool
detect
hcv
rna
hepat
c
viru
hcv
pandem
becom
major
public
health
concern
increas
preval
nearli
million
individu
infect
worldwid
major
acut
hcv
infect
present
asymptomat
cours
mani
infect
individu
therefor
seen
medic
set
nearli
infect
peopl
develop
persist
infect
risk
longterm
complic
rang
mild
liver
damag
sever
chronic
hepat
develop
cirrhosi
endstag
liver
diseas
hepatocellular
carcinoma
therefor
rapid
accur
diagnosi
hcv
import
prevent
viral
transmiss
manag
diseas
progress
screen
antibodi
hcv
howev
reliabl
method
diagnos
acut
hcv
infect
sinc
appear
antibodi
hcv
delay
patient
onset
symptom
moreov
window
period
even
longer
immunocompromis
patient
need
screen
routin
hcv
viremia
nucleicacidbas
detect
techniqu
current
reliabl
method
detect
hcv
infect
varieti
molecular
diagnost
assay
revers
transcriptas
pcr
nucleicacidsequencebas
amplif
transcriptionmedi
amplif
branchedchain
dna
assay
inhous
realtim
pcr
develop
detect
hcv
rna
assay
whether
qualit
quantit
rel
timeconsum
laborintens
depend
special
equip
resourcelimit
pointofcar
set
cost
technolog
requir
limit
univers
applic
sinc
hcvinfect
individu
asymptomat
clear
advantag
target
screen
hcv
high
risk
earlier
detect
infect
result
earlier
treatment
thu
earlier
recoveri
reason
still
great
need
tool
simplifi
detect
hcv
rna
accept
sensit
specif
short
turnaround
time
costeffect
loopmedi
isotherm
amplif
lamp
novel
rapid
accur
econom
nucleic
acid
test
method
character
employ
dna
polymeras
stranddisplac
activ
along
two
inner
primer
fip
bip
two
outer
primer
form
autocycl
immedi
loop
primer
lf
lb
first
describ
nagamin
et
al
could
acceler
enhanc
sensit
lamp
assay
onestep
lamp
assay
success
appli
rapid
detect
number
rna
virus
influenza
viru
mump
viru
west
nile
viru
sever
acut
respiratori
syndrom
corona
viru
lamp
assay
also
develop
detect
hepat
virus
hepat
b
viru
hepat
viru
hepat
e
viru
present
howev
hcv
detect
assay
use
method
report
attribut
hcv
target
may
interfer
complex
way
lamp
method
instanc
although
viral
untransl
region
utr
thought
conserv
portion
hcv
genom
target
almost
commerci
inhous
test
one
import
issu
may
exist
complex
secondari
structur
across
region
fig
also
utr
gener
consid
variabl
enough
distinguish
major
type
mani
subtyp
hcv
studi
describ
develop
modifi
lamp
method
rapid
econom
detect
hcv
rna
contrast
routin
lamp
prelamp
method
design
acceler
primer
ap
test
perform
apbas
lamp
assay
aplamp
new
assay
evalu
use
clinic
sampl
clinic
specimen
standard
twentyf
blood
sampl
collect
patient
confirm
chronic
hcv
infect
specimen
obtain
patient
suspect
viral
hepat
admit
hangzhou
th
infecti
hospit
use
evalu
studi
confirm
case
hcv
infect
verifi
posit
result
enzymelink
immunosorb
assay
kehua
bioengin
shanghai
china
antibodi
hcv
quantit
realtim
pcr
hcv
rna
panel
sampl
collect
healthi
blood
donor
also
includ
neg
control
addit
five
antihivantibodi
antihavantibodyand
hbvdnaposit
sampl
obtain
correspond
patient
also
test
inform
consent
obtain
patient
studi
approv
local
ethic
committe
per
declar
helsinki
five
millilit
blood
collect
subject
tube
contain
edta
plasma
immedi
separ
centrifug
rpm
inhous
hcv
rna
standard
obtain
extract
rna
hcvrnaposit
specimen
hcv
titer
iuml
inhous
standard
antihcv
antibodi
posit
calibr
triplic
parallel
nation
hcv
rna
refer
materi
iuml
iuml
genotyp
use
sever
commerci
realtim
pcr
test
kehua
bioengin
shanghai
china
daan
biotech
guangzhou
china
panel
calibr
use
hcv
intern
standard
nibsc
hcv
genotyp
perform
use
sequenc
region
hcv
genom
describ
previous
sequenc
analysi
indic
hcv
genotyp
inhous
standard
serial
dilut
standard
sampl
experiment
analysi
prepar
normal
human
plasma
store
test
viral
rna
extract
plasma
use
tianamp
viru
rna
kit
tiangen
biotech
beij
china
per
manufactur
instruct
extract
protocol
use
fast
spincolumn
procedur
rna
elut
rnasefre
water
whole
extract
procedur
done
within
hour
design
assay
detect
genotyp
preval
hcv
strain
individu
sequenc
utr
region
hcv
strain
hcv
databas
http
hcvlanlgov
retriev
align
analysi
conserv
fragment
utr
use
design
primer
set
hcv
genotyp
sequenc
genbank
access
number
chosen
repres
strain
use
refer
gener
set
primer
primer
includ
two
outer
two
inner
fip
bip
two
loop
primer
lf
lb
design
accord
guidelin
provid
primerexplor
http
loopampeikencojp
set
fip
consist
complementari
sequenc
sequenc
bip
consist
sequenc
complementari
sequenc
locat
outsid
loop
primer
recogn
region
strengthen
power
lamp
addit
acceler
primer
ap
locat
ad
primer
set
schemat
represent
locat
primer
along
repres
align
main
hcv
strain
shown
fig
detail
oligonucleotid
primer
use
amplif
given
tabl
primer
synthes
invitrogen
invitrogen
shanghai
china
routin
onestep
lamp
prelamp
reaction
carri
final
volum
contain
pmol
fip
bip
inner
primer
pmol
lf
lb
loop
primer
pmol
outer
primer
thermopol
buffer
new
england
biolab
beverli
mm
mgcl
betain
sigma
aldrich
usa
mm
deoxynucleotid
triphosph
u
bst
dna
polymeras
new
england
biolab
beverli
u
amv
revers
transcriptas
takara
dalian
china
templat
mixtur
incub
min
heat
min
termin
reaction
aplamp
assay
reaction
mixtur
condit
describ
prelamp
except
pmol
ap
ad
reaction
mixtur
neg
control
includ
lamp
run
serial
dilut
standard
use
templat
lamp
assay
evalu
sensit
specif
assay
test
sampl
hav
hbv
hivinfect
patient
healthi
donor
amplif
amplifi
dna
product
analyz
electrophoresi
agaros
gel
stain
ethidium
bromid
visual
use
biorad
transillumin
restrict
enzym
nhei
smai
new
england
biolab
beverli
use
digest
amplifi
product
confirm
amplif
specif
digest
product
analyz
gel
electrophoresi
agaros
gel
nakedey
visual
one
microlitr
dilut
sybr
green
invitrogen
carlsbad
ca
ad
reaction
tube
amplif
reaction
observ
visual
posit
reaction
chang
color
reaction
solut
orang
fluoresc
green
could
recogn
realtim
monitor
lamp
reaction
reaction
perform
abi
prism
sequenc
detect
system
sybrgreen
invitrogen
carlsbad
ca
ad
reaction
mixtur
provid
fluoresc
signal
run
set
follow
cycl
min
cycl
correspond
min
reaction
fluoresc
read
end
cycl
commerci
hcv
rna
realtim
pcr
detect
kit
kehua
bioengin
shanghai
china
use
accord
manufactur
instruct
templat
rna
extract
use
reaction
clinic
sensit
quantit
kit
iuml
design
lamp
primer
set
cover
main
genotyp
hcv
isol
multipl
sequenc
align
includ
genotyp
gener
retriev
align
sequenc
store
hcv
databas
http
wwwhcv
lanlgov
primer
design
maintain
maximum
conserv
anneal
target
region
mismatch
end
fipbip
substitut
degener
base
tabl
databas
search
use
blast
ncbi
show
primer
specif
hcv
genom
routin
lamp
format
prelamp
hcvspecif
assay
perform
use
rna
templat
extract
standard
sampl
amplifi
dna
product
subject
electrophoresi
agaros
gel
visual
uv
light
ethidium
bromid
stain
result
typic
lamp
ladder
pattern
observ
indic
differ
replic
intermedi
stemloop
amplif
process
band
obtain
notempl
control
eletrophoresisbas
monitor
prelamp
product
show
sensit
iuml
fig
test
specif
test
amplifi
product
digest
enzym
nhei
result
detect
strong
band
fig
lane
furthermor
possibl
crossreact
virus
known
caus
similar
clinic
sign
also
investig
amplif
viral
rna
dna
extract
hbv
hav
hivposit
sampl
detect
fig
improv
effici
detect
acceler
primer
ap
design
form
addit
synthesisstart
site
differ
loop
primer
bind
singl
strand
region
classic
lamp
ap
design
complementari
one
doublestrand
region
fig
ad
ap
prelamp
reaction
assay
name
aplamp
carri
evalu
perform
serial
dilut
templat
amplifi
aplamp
assay
shown
fig
onestep
aplamp
assay
detect
limit
iuml
rna
templat
specif
test
includ
restrict
enzym
analysi
use
neg
sampl
also
conduct
show
crossreact
sinc
visual
amplif
product
lamp
reaction
without
special
equip
would
make
assay
wide
applic
avail
sybr
green
ad
reaction
mixtur
result
color
chang
orang
green
amplifi
product
yield
green
color
posit
aplamp
reaction
demonstr
sensit
assay
equal
eletrophoresi
fig
given
sensit
aplamp
assay
detect
hcv
higher
prelamp
method
pathway
apbas
amplif
investig
dumbbelllik
intermedi
initi
autocycl
product
subsequ
amplif
step
lamp
assay
apart
classic
lamp
pathway
follow
use
fip
bip
describ
elsewher
ap
pathway
involv
synthesi
via
ap
prime
promot
elong
follow
fip
selfprim
characterist
featur
product
ap
pathway
end
product
partli
deriv
concaten
apfip
fragment
fig
importantli
ap
pathway
follow
assay
logic
specul
amplif
would
still
occur
without
outer
primer
name
lamp
studi
strictli
requir
classic
lamp
three
lamp
format
shown
fig
test
hypothesi
compar
prelamp
aplamp
lamp
assay
use
templat
panel
serial
log
dilut
hcv
rna
known
concentr
test
use
aplamp
prelamp
lamp
assay
realtim
platform
result
dilut
test
batch
three
replic
two
separ
run
given
tabl
aplamp
assay
averag
threshold
time
tt
requir
detect
posit
signal
rang
min
mean
sd
iu
rna
present
min
iu
rna
present
compar
min
prelamp
assay
min
lamp
assay
tt
valu
defin
reaction
time
necessari
achiev
posit
signal
baselin
result
demonstr
aplamp
assay
faster
min
prelamp
reaction
much
faster
realtim
pcr
furthermor
use
assay
analyz
lowconcentr
standard
rang
iu
amplif
obtain
templat
concentr
less
iuml
prelamp
assay
realtim
aplamp
assay
consist
detect
hcv
rna
level
iuml
three
six
lamp
assay
detect
hcv
rna
probit
regress
analysi
aplamp
method
detect
iuml
probabl
posit
result
compar
iuml
iuml
prelamp
lamp
assay
respect
therefor
sensit
aplamp
assay
detect
hcv
two
time
higher
lamp
assay
nine
time
higher
prelamp
assay
compar
electrophoresi
band
product
aplamp
lamp
prelamp
assay
first
two
show
similar
pattern
main
differ
aplamp
prelamp
assay
ladderlik
band
bp
band
region
rectangl
broken
line
fig
like
correspond
selfprim
amplif
product
bound
end
ap
fip
stemloop
structur
bp
size
match
expect
size
appathway
product
moreov
result
lamp
assay
provid
evid
ap
pathway
use
amplif
sever
report
indic
lamp
assay
strictli
requir
strand
displac
function
outer
primer
lamp
amplif
occur
fip
bip
absent
use
ap
assay
studi
use
realtim
monitor
agaros
gel
electrophoresi
confirm
outer
primer
extract
rna
templat
prepar
standard
plasma
subject
analysi
prelamp
lamp
method
prelamp
assay
use
serial
dilut
iuml
iuml
b
lamp
assay
use
templat
concentr
iu
iuml
c
lowconcentr
standard
rang
iuml
detect
prelamp
assay
standard
rang
iuml
detect
lamp
reaction
dash
box
indic
band
pattern
signific
differ
two
assay
requir
lamp
assay
higher
sensit
prelamp
assay
less
sensit
aplamp
assay
type
also
show
lower
stabil
aplamp
especi
sampl
low
concentr
addit
take
account
similar
band
pattern
aplamp
lamp
assay
result
indic
apprimingbas
amplif
inferior
classic
pathway
lamp
process
amplifi
product
digest
two
restrict
endonucleas
confirm
specif
structur
amplifi
product
three
differ
lamp
assay
restrict
enzym
smai
recogn
sequenc
nhei
cut
product
amplifi
specif
form
structur
shown
fig
nhei
digest
would
yield
fragment
bp
smai
digest
would
yield
fragment
bp
sinc
amplifi
product
concaten
dna
fragment
differ
size
amplif
kinet
probabl
affect
actual
end
product
lamp
reaction
due
cut
region
nheidigest
band
observ
approxim
bp
prelamp
product
contrast
bp
aplamp
lamp
product
cut
region
size
fragment
gener
smai
digest
approxim
bp
fig
good
agreement
predict
size
feasibl
aplamp
assay
detect
hcv
clinic
materi
assess
use
posit
neg
plasma
specimen
realtim
pcr
assay
perform
simultan
result
tabl
sampl
collect
healthi
volunt
test
neg
aplamp
realtim
pcr
total
sampl
obtain
chronic
hcv
patient
genotyp
n
genotyp
n
antihcv
posit
viral
load
rang
iuml
none
sampl
miss
aplamp
assay
acutephas
sampl
collect
patient
suspect
viral
hepat
three
antihcv
posit
also
detect
aplamp
remain
antihcvneg
case
two
posit
hcv
rna
aplamp
two
patient
later
seroconvert
month
respect
tabl
aplamp
gave
total
posit
result
result
obtain
realtim
pcr
total
aplamp
method
demonstr
agreement
realtim
pcr
use
analysi
clinic
sampl
preliminari
result
suggest
aplamp
assay
describ
appli
diagnosi
hcv
infect
clinic
set
among
nucleic
acid
amplif
test
avail
date
lamp
method
mani
characterist
make
suitabl
rapid
sensit
simpl
detect
pathogen
adapt
lamp
technolog
hcv
detect
pointofcar
resourcelimit
set
mani
potenti
advantag
exampl
reaction
occur
isotherm
condit
thu
requir
special
equip
power
amplif
effici
lamp
assay
make
extrem
rapid
exhibit
high
analyt
sensit
furthermor
end
product
observ
immedi
visual
observ
turbid
dye
stain
howev
hcv
nucleic
acid
test
avail
outsid
laboratori
set
possibl
due
time
cost
technolog
limit
use
multipl
primer
combin
one
key
featur
lamp
method
affect
primer
select
given
templat
hcv
complex
order
secondari
structur
genotyp
variat
site
simultan
devis
acceler
primer
improv
effici
amplif
like
loop
primer
lamp
ap
provid
addit
start
site
dna
synthesi
fig
amplif
therebi
reduc
overal
reaction
time
increas
sensit
mention
howev
lamp
reaction
loop
region
alway
singlestrand
state
process
contrast
ap
locat
doublestrand
region
complementari
one
strand
compar
perform
aplamp
prelamp
assay
higher
amplif
effici
found
former
possibl
explan
apart
classic
amplif
process
lamp
assay
apbas
amplif
pathway
aplamp
method
notion
support
follow
evid
first
compar
band
pattern
aplamp
prelamp
product
ap
pathway
apfip
observ
former
next
lamp
assay
still
amplifi
target
absenc
outer
primer
classic
lamp
format
outer
primer
import
strand
displac
form
autocycl
intermedi
product
amplif
occur
without
primer
final
digest
end
product
restrict
enzym
recogn
differ
site
target
favor
structur
amplifi
product
found
length
polymorph
analysi
shown
fig
well
known
primer
design
lamp
complex
difficult
pcr
sinc
lamp
reaction
effici
sensit
strongli
depend
primer
select
flexibl
way
lamp
primer
design
could
promot
use
method
sum
point
ap
strategi
could
appli
lamp
design
meet
special
demand
certain
condit
instanc
end
fipbip
secondari
structur
play
key
role
amplif
cycl
lampbas
assay
use
ap
could
reduc
problem
select
fipbip
ad
ap
principl
ap
lamp
amplif
three
lamp
format
studi
primer
commonli
use
lamp
assay
prelamp
includ
inner
primer
fip
bip
outer
primer
loop
primer
lf
lb
loop
primer
anneal
partial
singlestrand
portion
ap
devis
studi
addit
acceler
primer
locat
fragment
lamp
assay
use
outer
primer
b
cyclic
amplif
step
ap
pathway
illustr
dsdna
reach
dynam
equilibrium
thu
ap
bind
partli
free
end
templat
initi
strand
extens
complement
hairpin
structur
induc
selfprim
dna
synthesi
preoptim
lamp
assay
could
avoid
need
design
differ
primer
set
optim
perform
aplamp
investig
studi
run
aplamp
assay
realtim
pcr
machin
consist
achiev
lower
limit
detect
iuml
probit
analysi
sensit
compar
seri
inhous
test
publish
recent
although
method
essenti
qualit
outset
sensit
limit
repres
good
perform
sinc
hcv
plasma
viremia
acut
infect
gener
higher
copiesml
expect
specif
test
use
seroneg
sampl
nontarget
viru
sampl
demonstr
exclus
assay
appli
aplamp
assay
clinic
specimen
agreement
aplamp
realtim
pcr
test
aplamp
method
consist
detect
hcvinfect
sampl
broad
rang
viral
load
sinc
sampl
compris
hcv
genotyp
preval
china
aplamp
assay
expect
work
major
hcvinfect
individu
local
region
high
mutat
rate
hcv
easi
gener
singl
lamp
primer
set
detect
everi
viral
strain
individu
subtyp
degener
design
common
way
address
issu
genotyp
inclus
may
lower
diagnost
sensit
due
hybrid
effect
reason
ap
strategi
develop
would
potenti
applic
situat
like
futur
evalu
detect
effici
use
extens
collect
hcv
genotyp
larger
sampl
would
desir
valid
perform
assay
addit
high
sensit
specif
aplamp
assay
major
advantag
rapid
flexibl
detect
method
aplamp
assay
could
carri
less
min
h
includ
extract
step
need
perform
lamp
assay
compar
h
realtim
pcr
assay
amplif
lamp
assay
detect
nake
eye
form
visual
fluoresc
eg
origin
orang
color
dye
chang
green
natur
light
case
posit
amplif
reaction
thu
elimin
need
gel
electrophoresi
realtim
monitor
result
well
result
previou
studi
use
fluoresc
reagent
detect
lamp
product
visual
show
similar
detect
effici
compar
realtim
pcr
electrophoresi
therefor
hcvspecif
lamp
assay
may
applic
clinic
field
condit
conclus
demonstr
use
hcv
develop
lamp
test
use
novel
principl
base
acceler
primer
provid
altern
way
design
lamp
assay
complex
target
studi
present
sensit
specif
lamp
method
screen
confirm
infect
hcv
simpl
rapid
costeffect
manner
loopmedi
isotherm
amplif
assay
hcv
